Nkarta NKTX
NASDAQ NKTX
$1.77 +0.03 (+1.72%)
As of: Oct 23, 2026 · 3:20 PM EDT

Nkarta (NKTX) Revenue (2019)

Updated

Nkarta's Revenue was $115,000 in FY2019.

Analysis

Nkarta (NKTX) Revenue (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,129.96 Bn 1,098.54 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn 25.40 Bn
3 AbbVie 504.89 Bn 478.00 Bn 12.70 Bn 16.99 Bn
4 Merck 358.50 Bn 312.87 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 291.04 Bn 255.03 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.27 Bn 238.95 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.76 Bn 193.16 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 195.00 Bn 169.20 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.37 Bn 118.02 Bn 10.94 Bn 15.03 Bn
10 Nkarta 132.23 Mn -1.55 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -385.00
Jun 30, 2019 2,308.00
API Access

Nkarta Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NKTX&period=max&api_key=YOUR_API_KEY